Another year, another B!
April 8, 2024 | Carbon Disclosure, Climate change, Pharma, Sustainability, healthcare comms
Louise Jones, Cuttsy+Cuttsy’s Sustainability Officer reflects on their latest year of carbon reporting through CDP and on achieving another B rating.
Yes, we’ve been awarded another B rating from Carbon Disclosure Project (CDP)! This is the second-highest rating available from CDP (which monitors environmental impact and risk management) and shows that we have been able to maintain our commitment to sustainability for the past 12 months, resulting in us being rewarded with another top rating!
The past year has been particularly momentous for us; we achieved net zero in both Scopes 1 and 2 (you’ll find more about the scope definitions here), which means we have just Scope 3 to conquer. Scope 3, which encompasses emissions resulting from the entire value chain, represents our last barrier to becoming a net zero company. And while achieving true net zero may be a challenge given the current technological landscape, our commitment is unwavering. We’re absolutely determined to get as close to zero as humanly possible!
Disclosing our progress through CDP is a crucial part of our bigger sustainability strategy, and with two years of experience under our belts, we’re embracing new changes in CDP’s submission structure as we head into 2024.
We’ve definitely encountered some roadblocks along the way. The main one being the complexity and time needed to accurately carbon report.
But there is light – after attending the CDP conference last year, we were given the welcome news of the questionnaire’s re-design, which hugely simplifies the reporting process. Firstly, by improving user-friendliness, and secondly (which is likely to be a very significant and far-reaching change), the merging of the climate, forestry, and water questionnaires. This promises to not only streamline the reporting process but for the likes of yours truly who is tasked with annual reporting, brings huge relief!
These changes are also likely to be big drivers in getting get more companies to participate in the scheme and disclose the details of their sustainability efforts. Because an accurate measurement of everyone’s impact is, after all, the only way to achieve true and effective global change. And CDP are clearly showing their commitment to this critical goal.
As we navigate through these improvements and challenges, Cuttsy+Cuttsy remains steadfast in its commitment to sustainability. And we look forward to making even greater strides in the coming years. Here’s to another year of progress and collective efforts towards a sustainable future.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Cuttsy+Cuttsy achieves Platinum accreditation from Investors in People
Cuttsy+Cuttsy is proud to have achieved a Platinum accreditation from Investors in People, placing them among the top 2% of organisations assessed globally.
Cuttsy+Cuttsy awarded Gold EcoVadis sustainability rating
Cuttsy+Cuttsy proudly announces their Gold Medal achievement from EcoVadis for 2024, placing them among the top 5% of companies assessed and within the 97th percentile, a testament to their unwavering...
Age is not just a number when it comes to clinical trials
In this blog we look at the critical underrepresentation of older adults in clinical trials, emphasising the need for inclusive trial designs and targeted strategies to ensure safe and effective...
How to boost clinical trial access and make patients health-empowered
Clinical research is becoming more patient-centric, but there's still more that needs to be done to make clinical trials available to everyone. This could include wider participation.
Closing the loop: Why clinical trial results matter to participants
Discover why sharing clinical trial results with participants is crucial for respect, informed health decisions, and fostering strong researcher-participant partnerships.
Unveiling the truth: A journey into women’s representation in clinical trials
We explore the historical exclusion of women from clinical trials, its consequences on medical research and treatment efficacy and the ongoing efforts to ensure their representation.
Clarity in clinical trials
Discover how transparent, empathetic communication and health literacy principles can empower patients and enhance engagement in clinical trials, transforming participants into active partners in their healthcare journey.
Caring for patients’ mental health in clinical trials
We look at why ensuring continuous mental health support for patients in clinical trials is essential to enhance their overall well-being and trial engagement.
Driving equitable healthcare: The role of DE&I in clinical trials
Diversity, equity and inclusion (DE&I) is becoming a bigger topic of conversation and meaningful action within clinical trials. And for good reason, too. Find out why we embrace this and...
Empowering patients through more accessible clinical trial information
Senior Medical Writer, Scott Palmer explores the challenges and solutions in enhancing patient engagement in clinical trials, from the pivotal role of healthcare professionals, to the importance of user-friendly trial...